FDA Import Refusal 274-0272684-1/11/1 — Lupin Pharmaceuticals Inc.
The FDA refused shipment 274-0272684-1/11/1 from Lupin Pharmaceuticals Inc. (United States) on Feb 24, 2022. The refused product falls under Drugs and Biologics — LISINOPRIL (ANTI-HYPERTENSIVE). Cited charge: 3340 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- Feb 24, 2022
- Country
- United States
- Product Category
- Drugs and Biologics
- Product Code
- 62CDB65 LISINOPRIL (ANTI-HYPERTENSIVE)
- Charges
- 3340